State-dependent reductions in serotonin delivery to upper airway dilator motoneuron activity may contribute to sleep apnea. The functional significance of serotonin receptor subtypes implicated in excitation of dilator motor neurons was evaluated in anesthetized, paralyzed, mechanically-ventilated adult rats (n=108). Effects of antagonists selective for serotonin receptor subtypes 2A, 2C or 7 on intrinsic hypoglossal activity and on serotonin agonist (serotonin, 5-carboxamidotryptamine maleate, and RO-60,0175) dose-responses were characterized. All drugs were injected unilaterally into the hypoglossal nucleus. The 2A-antagonist, MDL-100,907, dropped intrinsic hypoglossal nerve respiratory activity by 61%±6, p<0.001) and suppressed serotonin excitation of hypoglossal nerve activity, p<0.05. The 2C-antagonist, SB-242,084, dropped hypoglossal nerve activity 17%±6, p<0.05 and suppressed the dose-response curve for the 2C-agonist. Rapid desensitization occurred with the 2C-agonist only (p<0.05). The 7-antagonist, SB-269,970, had no effect on either intrinsic activity or agonist responses. We conclude that serotonin 2A is the predominant excitatory serotonin receptor subtype at hypoglossal motor neurons. The serotonin 2C excitatory effects are of lower magnitude and associated with rapid desensitization. There is no evidence for serotonin 7 activity in the hypoglossal nucleus. This characterization of serotonin receptor subtypes in the hypoglossal nucleus provides a focus for the development of pharmacotherapies for sleep apnea.
Introduction
Obstructive sleep apnea hypopnea syndrome (OSAHS) is present in > 2% of adults (1) and has been identified as an independent risk factor for several cardiovascular disease processes (2) (3) (4) (5) .
Safe and widely effective pharmacotherapies are needed for OSAHS.
The pathophysiology of this disease, with compromised respiration only in sleep (6) (7) (8) ,
suggests that this disorder should be amenable to drug therapies that would prevent sleep-related reductions in upper airway dilator motoneuronal activity. State-dependent changes in neurotransmitter delivery are complex and involve alterations in the delivery of many different neurochemicals in multiple regions involved in the control of respiratory drive to upper airway motor neurons (9, 10 ). An understanding of the neurochemical changes at all of these regions will be necessary to develop the most effective pharmacotherapies for OSAHS. We have chosen to focus, first, on changes occurring directly at dilator motor neurons. Here, we hypothesize that serotonin (5-HT) contributes, at least in part, to the state-dependent reductions in dilator motoneuronal activity.
The rationale to focus on 5-HT at upper airway motor neurons is based on the following observations. 5-HT excites adult upper airway dilator motor neurons (11) (12) (13) (14) (15) (16) (17) , and provides intrinsic excitation at brainstem motor neurons in unanesthetized animals (13) . The activity of neurons supplying 5-HT to motor neurons declines in sleep (18, 19) . Further, pre-treatment of upper airway dilator motor neurons with 5-HT reduces sleep state-dependent suppression in upper airway dilator muscle activity (20) .
The pharmacology of 5-HT modulation of upper airway dilator motor neurons is complex and appears to involve multiple 5-HT receptor subtypes (21) (22) (23) (24) (25) (26) (27) (28) (29) . An understanding of receptor subtypes is essential for targeting drug therapies. Previous studies with partially selective 5-HT BLUE200202-107OCR2 agonists and antagonists have suggested an excitatory effect through one or more of the 5-HT 2 receptor subtypes (11, 15, 21, 23, (27) (28) (29) . 5-carboxyamido-tryptamine (a 5-HT agonist with greater affinity at 5-HT 1 and 7 ), however, also appears effective in exciting hypoglossal neurons (15) . We recently measured mRNA copy numbers for 8 post-synaptic 5-HT receptor subtypes in individual XII motor neurons and found that 5-HT 2A was the predominant receptor subtype in motor neurons, and the mRNA for this receptor subtype was present in all XII motor neurons (30) . Smaller amounts of 5-HT 2C were identified in half of the motor neurons, dispersed throughout the hypoglossal nucleus. The functional significance of mRNA for each of these receptor subtypes has not been characterized.
The purpose of the present work was: (1) to determine if either 5-HT 2A 2C and/or 7 receptors contribute to 5-HT excitation within a representative upper airway motor nucleus, the XII, and (2) to determine if the 5-CT effect is mediated via activation of 5-HT 7 receptors.
Methods

Surgery
Adult male Sprague-Dawley rats (Charles River) weighing 350-390 g were pre-anesthetized with halothane (2.0-2.5%) and then anesthetized with urethane 1.2 g/kg intraperitoneally (31) . A femoral arterial line, femoral venous line, and tracheotomy tube were placed; the vagi were transected distal to the nodose ganglion (32) . Cuff electrodes (self-fashioned) were placed on both hypoglossal nerves for recording. Blood pressure, end tidal CO 2 and both hypoglossal nerves were recorded, following paralysis with pancuronium and mechanial ventilation as previously described (32) . The dorsal surface of the medulla was exposed for microinjections.
Procedures were approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania. All drugs were solubilized in normal saline.
BLUE200202-107OCR2
Drugs
Drugs were administered as microinjections targeting one hypoglossal nucleus using coordinates relative to the calamus scriptorius (0.2mm lat, 1.05 ventral, and 0.2-0.6 mm rostral).
The main effect measured was ipsilateral hypoglossal nerve activity using methods as previously detailed (15, 31, 33) and illustrated in figure 1.
5-HT and 5-CT (non-selective agonist) effects on XII nerve activity protocol
Effects of 5-HT and 5-CT on XII nerve activity were assessed in 35 rats, each receiving 5-6 microinjections (20nl each) targeted at the ventral region of the XII nucleus (34) , as shown in figure 2 . Table 1 summarizes the concentrations tested and the number of animals per condition.
The order of drug and concentration (including saline control) were randomized for each rat, with the exception that if randomized to a 5 mM dose, this would be administered last. Effect was measured 30 seconds following injection. The interval between injections was 10 minutes BLUE200202-107OCR2 (32) .
RO (2C agonist) effects on XII nerve activity
Effects of RO (2C agonist) on XII nerve respiratory activity were evaluated in a separate 20 rats.
Each rat received three injections of randomly selected doses, as above for 5-HT and 5-CT.
Effect was measured 30 seconds following injection. The interval between injections was one hour.
Effects of 5-HT antagonists on baseline XII nerve activity
In a separate 25 rats one of 5 antagonists was tested to characterize the effect of the drug on baseline XII nerve activity. For each of these trials, each rat received three 20 nl injections: one into the site used for agonist injections and then one 0.2 mm rostral and one 0.2 mm caudal to that site. Effect of antagonist was measured 15 minutes after the third injection. Following MDL (2A antagonist) injections, MTP (using same dosing) was injected as above to assess for additional effect.
Effects of selective antagonists on 5-HT, 5-CT and RO (2C agonist) dose-response curves
In 20 of the 25 rats used in the antagonist protocol above, in all 35 rats used in the 5-HT, 5-CT dose response curves and in an additional 18 rats without prior injections, effects of selective antagonists on dose responses were tested. The effects of one antagonist on agonist doseresponse curves were tested per animal, using the same randomized doses shown in Table 1 . Five minutes following the three-20 nl antagonist injections, agonist dose responses were performed as in the above agonist protocol.
BLUE200202-107OCR2
Histological confirmation of drug placement into the XII nucleus
Following completion of the above studies, a final injection (20nl) of 5mM 5-HT with Pontamine Blue dye was injected at the same coordinates used for agonist injection studies. The animal was then euthanized with 1 gm urethane IV and the brainstem was prepared for histological review after counter-staining with Neutral Red, as in Figure 2 .
Data Analysis
The main effect analyzed was percentage change in XII nerve peak respiratory activity, relative to baseline XII nerve respiratory amplitude (15, 32, 33) . Data analyzed and reported were obtained from recording periods with stable blood pressure and end-tidal CO 2 signals. One-way analysis of variance was used to determine overall effect of agonist on excitation of XII motor neurons. Where the ANOVA F test was <0.05 and a Gaussian distribution was confirmed for all but normal saline condition, a Tukey-Kramer multiple comparison of means was performed for specific concentrations compared to saline. Antagonist effect on baseline was examined using the Student's paired t -test with Bonferroni correction. Antagonist effect on agonist doseresponse was performed with two-way ANOVA.
Results
Dose responses for 5-HT, 5-CT and RO 60-0175
A summary of effects of drugs, sample sizes, range of effect and statistical significance of effect relative to saline injection is provided in Table 1 . Dose-response curves are illustrated in Figure   3 . The response pattern of RO (2C agonist) differed from that of 5-HT in several ways. First, the maximum response (at 1000uM) was significantly less in the RO (2C agonist) trials (twotailed unpaired t, t =2.4, P<0.05). In addition, the lowest dose for which a significant increase BLUE200202-107OCR2 was observed was 0.1 uM for 5-HT (p<0.05) and 10 uM for RO (2C agonist) (p<0.01). Finally, RO (2C agonist) injections resulted in a rapid desensitization, as shown in Figure 4 .
Baseline XII nerve activity response to selective 5-HT antagonists injected into the XII nucleus
The effects of five different antagonists were tested on baseline XII nerve activity, and are summarized in Figure 5 . The largest effect was seen with the MDL (2A antagonist) (62%±7 reduction in respiratory activity, n = 5, p < 0.01). MTP (broad spectrum antagonist) injected after MDL (2A antagonist) did not result in a further reduction in activity, 65%±17, n=4, paired t, t=0.9, N.S.
Effects of selective 5-HT antagonists on dose response curves of 5-HT, 5-CT and RO 60-0175
The effects of selective antagonists on the 5-HT and 5-CT (broad spectrum agonist) dose response curves are depicted in 
Pharmacological characterization of serotonergic XII motoneuron excitation
Results in the present study provide several lines of evidence for a strong 5-HT 2A excitatory effect at XII motor neurons. Specifically, the 5-HT 2A antagonist is highly selective (by several log-fold differences) for the 5-HT 2A receptor (35) . This drug at a small concentration almost completely blocks the 5-HT excitation of XII nerve activity, and methiotepin, a drug with greater affinity at 5-HT receptor subtypes other than 2A, does not add to this suppression (36) . propylamino)-tetralin (8-OH DPAT), a 5-HT 1 and 7 agonist, has a predominantly inhibitory effect on XII respiratory activity, consistent with a 5-HT 1 effect, rather than 5-HT 7 (39) .
The presence of two related 5-HT receptor subtypes within the XII nucleus. It is of interest that
XII motor neurons have two very similarly configured 5-HT excitatory receptors with seemingly similar signal transduction (2A and 2C) . In the present study we have shown that activation of each of these receptor subtypes results in distinct XII nerve activity responses, distinguished by magnitude of effect and rapid desensitization. Until recently, cellular signal transduction mechanisms were believed to be similar for the 2A and 2C receptor subtypes (43) . One exception recently identified is that the 2C receptor is more prone to desensitization than 2A (in vitro, on similar cells). Moreover, very high receptor occupancy (>99%) restores 2A responsiveness, but not that of 2C (37) . The differences in desensitization and resensitization relate to which protein kinases are activated, e.g., PKC or calmodulin-dependent PK II (41) . We hypothesize that these differences in protein kinase activation result in differences in glutamate receptor subtype activation, and this may explain differences in desensitization. Understanding how the sensitization of upper airway motor neurons changes by receptor subtype activation and how upper airway obstruction, intermittent hypoxia and hypercarbia alter 5-HT excitation of upper airway motor neurons will be important in elucidating drugs for OSAHS.
5-HT depolarizes brainstem and spinal motor neurons through at least two mechanisms, a reduction in the resting potassium conductance and enhancement of the hyperpolarizationactivated inward rectifier current, I H (28, 29, 44) . Potassium channel closure is likely mediated by 5-HT 2A or 2C (17, 45) . Log Dose RO-60,0175 ( )
